AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2023
Jan 25, 2023
3695_dirs_2023-01-25_b1610530-c598-4e10-9073-0658283ec5bf.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anders Tuv | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member of the issuer | ||
| b) | Initial Notification / Amendment |
Initial | ||
| 3 | Details of the issuer | |||
| a) | Name | Nykode Therapeutics ASA | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 4 | Details of the transaction: | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | ||
| b) | Nature of the transaction |
Subscription of shares through exercise of warrants | ||
| c) | Price(s) and | |||
| volume(s) | Price | Volume(s) | ||
| NOK 2.50 | 400,000 | |||
| Price | Volume(s) | |||
| d) | Aggregated | NOK 18.00 | 400,000 | |
| information — Aggregated volume — Price |
Price | Volume(s) | ||
| NOK 8,200,000 | 800,000 | |||
| e) | Date of the | 2023-01-25 | ||
| transaction | ||||
| f) | Place of the transaction |
Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anders Tuv | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member of the issuer | ||
| b) | Initial Notification / Amendment |
Initial | ||
| 3 | Details of the issuer | |||
| a) | Name | Nykode Therapeutics ASA | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 4 | Details of the transaction: | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | ||
| b) | Nature of the transaction |
Sale of shares | ||
| c) | Price(s) and | |||
| volume(s) | Price | Volume(s) | ||
| NOK 28.00 | 475,000 | |||
| d) | Aggregated | |||
| information — Aggregated |
Price NOK 13,300,000 |
Volume(s) 475,000 |
||
| volume — Price |
||||
| e) | Date of the transaction |
2023-01-25 | ||
| f) | Place of the transaction |
The Oslo Stock Exchange |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Datum AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Person closely associated with Jan Haudemann-Andersen, board member of the issuer |
||
| b) | Initial Notification / Amendment |
Initial | ||
| 3 | Details of the issuer | |||
| a) | Name | Nykode Therapeutics ASA | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 4 | Details of the transaction: | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | ||
| b) | Nature of the transaction |
Lending of shares for settlement purposes | ||
| c) | Price(s) and volume(s) |
Price N/A |
Volume(s) 475,000 |
|
| d) | Aggregated information — Aggregated volume — Price |
Price N/A |
Volume(s) 475,000 |
|
| e) | Date of the transaction |
2023-01-25 | ||
| f) | Place of the transaction |
Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anders Tuv | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member of the issuer | ||
| b) | Initial Notification / Amendment |
Initial | ||
| 3 | Details of the issuer | |||
| a) | Name | Nykode Therapeutics ASA | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 4 | Details of the transaction: | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | ||
| b) | Nature of the transaction |
Borrowing of shares for settlement purposes | ||
| c) | Price(s) and | |||
| volume(s) | Price | Volume(s) | ||
| N/A | 475,000 | |||
| d) | Aggregated | |||
| information | Price | Volume(s) | ||
| — Aggregated volume |
N/A | 475,000 | ||
| — Price | ||||
| e) | Date of the | 2023-01-25 | ||
| transaction | ||||
| f) | Place of the | Outside a trading venue | ||
| transaction |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Anders Tuv | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Board member of the issuer | ||
| b) | Initial Notification / Amendment |
Initial | ||
| 3 | Details of the issuer | |||
| a) | Name | Nykode Therapeutics ASA | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 4 | Details of the transaction: | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | ||
| b) | Nature of the transaction |
Transfer of shares | ||
| c) | Price(s) and | |||
| volume(s) | Price | Volume(s) | ||
| NOK 28.00 | 325,000 | |||
| d) | Aggregated | |||
| information | Price | Volume(s) | ||
| — Aggregated volume |
NOK 9,100,000 | 325,000 | ||
| — Price | ||||
| e) | Date of the | 2023-01-25 | ||
| transaction | ||||
| f) | Place of the | Outside a trading venue | ||
| transaction |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Tuv Capital AS | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Person closely associated with Anders Tuv, board member of the issuer | ||
| b) | Initial Notification / Amendment |
Initial | ||
| 3 | Details of the issuer | |||
| a) | Name | Nykode Therapeutics ASA | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 4 | Details of the transaction: | |||
| a) | Description of the financial instrument, type of instrument Identification code |
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785 | ||
| b) | Nature of the transaction |
Acquisition of shares | ||
| c) | Price(s) and | |||
| volume(s) | Price | Volume(s) | ||
| NOK 28.00 | 325,000 | |||
| d) | Aggregated | |||
| information | Price | Volume(s) | ||
| — Aggregated volume |
NOK 9,100,000 | 325,000 | ||
| — Price | ||||
| e) | Date of the | 2023-01-25 | ||
| transaction | ||||
| f) | Place of the | Outside a trading venue | ||
| transaction |
More from Nykode Therapeutics ASA
Interim / Quarterly Report
2026
May 27
Earnings Release
2026
May 27
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30